INS018-055, A Novel Traf2- and NCK-interacting Kinase (TNIK) Inhibitor, Improves Lung Function in Patients With Idiopathic Pulmonary Fibrosis: Results From a Randomized, Double-blind, Placebo-controlled Phase 2a Study

Authors: Z. Xu, P. Wang, J. Cao, C. Tan, D. Ma, L. Zhao, T.M. Maher, A. Zhavoronkov, F. Ren, S. Rao, C. Satler, S. Liu, Y. Lv, H. Zhao, A. Aliper

Published: 2025-05-11

DOI: 10.1164/ajrccm.2025.211.abstracts.a2904

Source: Full article

---

Abstract

No abstract found.